Abstract
ABSTRACT: The effects of ascorbic acid on the excretion of homogentisic acid and its derivative benzoquinone acetic acid were studied in two adults and three infants. The administration of relatively large amounts of ascorbic acid to the adults was followed by a disappearance of benzoquinone acetic acid from the urine, whereas the level of excretion of homogentisic acid did not change. This could have relevance to the pathogenesis of ochronotic arthritis. In the 4-mo-old infant and the 5-mo-old infant ascorbic acid in the urine may have doubled the amount of homogentisic acid, presumably through an effect on the immature p-hydroxyphenylpyruvic acid oxidase. Dietary reduction of the intake of tyrosine and phenylalanine substantially reduced the excretion of homogentisic acid.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wolff, J., Barshop, B., Nyhan, W. et al. Effects of Ascorbic Acid in Alkaptonuria: Alterations in Benzoquinone Acetic Acid and an Ontogenic Effect in Infancy. Pediatr Res 26, 140–144 (1989). https://doi.org/10.1203/00006450-198908000-00015
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-198908000-00015
This article is cited by
-
Family history of ochronotic arthropathy
Rheumatology International (2021)
-
Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria
Scientific Reports (2019)
-
Alkaptonuria: A Case of Familial Inheritance from Hangarki Village in Dharwad District of Karnataka
Indian Journal of Clinical Biochemistry (2016)
-
Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria
Journal of Inherited Metabolic Disease (2015)
-
The Role of Nitisinone in Tyrosine Pathway Disorders
Current Rheumatology Reports (2014)